Publication
Article
Supplements and Featured Publications
MS Stakeholder Summit: New Treatment Landscape in Multiple Sclerosis (MS)—Preventing Long-Term Disability Through High-Efficacy Treatments in Early MSVolume
New Treatment Landscape in Multiple Sclerosis (MS)—Preventing Long-Term Disability Through High-Efficacy Treatments in Early MS
This AJMC® Stakeholder Summit provides a multistakeholder perspective on opportunities to improve long-term disease outcomes in multiple sclerosis, as well as clinical and payer considerations with early use of high-efficacy therapies.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
